Patent US5962482A successfully refreshed from Google Patents.
US5962482A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of reducing cellulite in mamalian skin
Assignee: Procter and Gamble Co
•
Filing: 1999-03-12
•
Granted: 1999-10-05
•
Expires: 2019-03-12
Abstract
Abstract The present invention relates to a method for combating cellulite or reducing localized fatty excesses which comprises administering to a person having cellulite or localized fatty excesses a body slimming amount of a composition containing niacinamide.
Inventors
- 👤 Donald Lynn Bissett
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 15:54
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/40; A61K8/42; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/455; A61K8/67; A61K8/673; A61K8/675; A61P; A61P17/00; A61Q; A61Q19/00; A61Q19/06
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
46 words
A method of treating and/or preventing cellulite by administering a safe and effective amount of a skin care composition to a mammal having, or prone to forming cellulite, comprising: a). a safe and effective amount of niacinamide; and b). a dermatologically acceptable carrier for the niacinamide.
Claim 2
Independent Claim
46 words
A method of treating and/or preventing cellulite by administering a safe and effective amount of a skin care composition to a mammal having, or prone to forming cellulite, comprising: a). a safe and effective amount of niacinamide; and b). a dermatologically acceptable carrier for the niacinamide.
Claim 3
Dependent Claim
17 words
A method according to claim 1, wherein the concentration of niacinamide from about 1% to about 20%.
Claim 4
Dependent Claim
12 words
A method according to claim 1, wherein the niacinamide is substantially uncomplexed.
Claim 5
Dependent Claim
32 words
A method according to claim 1, wherein the composition further comprises an additional active selected from the group consisting of phosphodiesterase inhibitors, oleosoluble vegetable extracts, herbal extracts, botannical extracts and mixtures thereof.
Claim 6
Dependent Claim
28 words
A method according to claim 4, wherein the additional active is a phosphodiesterase inhibitor selected from the group consisting of theophylline, caffeine, theobromine, salts thereof and mixtures thereof.
Claim 7
Dependent Claim
31 words
A method according to claim 1, wherein the composition further comprises an additional skin active selected from the group consisting of hydroxy acids, desquamatory agents, sunscreens, anti-oxidants, retinoids and mixtures thereof.
Claim 8
Dependent Claim
97 words
A method according to claim 6, wherein the hydroxy acid is salicylic acid; the desquamatory agent is selected from the group consisting of zwitterionic surfactants and mixtures thereof; the sun-block is selected from the group consisting of zinc oxide, titanium dioxide and mixtures thereof; the sunscreen is selected from the group consisting of 2-ethylhexyl-p-methoxycinnamate, 4,4'-t-butyl methoxydibenzoyl-methane, phenyl benzimidazole sulfonic acid, octocrylene and mixtures thereof; the anti-oxidant is selected from the group consisting of tocopherol, esters thereof and mixtures thereof; and the retinoid is selected from the group consisting of retinol, retinyl acetate, retinyl propionate, and mixtures thereof.
Claim 9
Dependent Claim
27 words
A method according to claim 1, wherein the skin care composition is contained within a patch or is applied to the skin and covered by a patch.
Claim 10
Dependent Claim
43 words
An article of manufacture comprising a skin care composition comprising from about 0.1% to about 40%, by weight, niacinamide in a package for said skin care composition in association with the information about and/or instructions on the use of niacinamide to treat cellulite.
Claim 11
Dependent Claim
43 words
An article of manufacture comprising a skin care composition comprising from about 0.1% to about 40%, by weight, niacinamide in a package for said skin care composition in association with the information about and/or instructions on the use of niacinamide to treat cellulite.
References Cited (Backward Citations)
FR2222008A1
Cited
US4086922A
Cited
US4829987A
Cited
US5658576A
Cited
US5514374A
Cited
US5591437A
Cited
DE4401308A1
Cited
US5536499A
Cited
US5705170A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-10-04 | 2003-04-05 | 2003-10-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-10-04 | 2007-04-05 | 2007-10-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-10-04 | 2011-04-05 | 2011-10-05 | $7700.00 | Window Closed / Lapsed |